Clearstead Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-7,692
| Closed | -$890K | – | 1665 |
|
2023
Q3 | $890K | Buy |
7,692
+3,846
| +100% | +$445K | 0.03% | 317 |
|
2023
Q2 | $396K | Hold |
3,846
| – | – | 0.02% | 325 |
|
2023
Q1 | $420K | Sell |
3,846
-91
| -2% | -$9.93K | 0.03% | 289 |
|
2022
Q4 | $448K | Hold |
3,937
| – | – | 0.04% | 268 |
|
2022
Q3 | $244K | Hold |
3,937
| – | – | 0.02% | 336 |
|
2022
Q2 | $314K | Buy |
3,937
+66
| +2% | +$5.26K | 0.02% | 306 |
|
2022
Q1 | $407K | Hold |
3,871
| – | – | 0.03% | 291 |
|
2021
Q4 | $417K | Hold |
3,871
| – | – | 0.03% | 277 |
|
2021
Q3 | $424K | Hold |
3,871
| – | – | 0.03% | 265 |
|
2021
Q2 | $362K | Hold |
3,871
| – | – | 0.03% | 262 |
|
2021
Q1 | $356K | Hold |
3,871
| – | – | 0.03% | 254 |
|
2020
Q4 | $283K | Hold |
3,871
| – | – | 0.03% | 274 |
|
2020
Q3 | $301K | Buy |
+3,871
| New | +$301K | 0.03% | 233 |
|